Digestive Disorders Treatment Worldwide

The Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample with state of the art, quantitative polymerase chain reaction (qPCR) technology. The GI-MAP was designed to detect microbes that may be disturbing normal microbial balance or contributing to illness as well as indicators of digestion, absorption, inflammation, and immune function. With a culture based test it is not possible to measure strict anaerobes, viruses or virulence factors.  The GI-MAP's accuracy and reliability allows personalized protocols to address gut dysfunction based on which infections are urgent, which areas of the gut are already optimized, and which areas should be addressed after an infection is resolved. Additionally, the quantification of identified micro-organisms offers a remarkable ability to see how treatment modalities are working because a retest after treatment can show whether a parasite has resolved, dysbiosis has improved, and more. Indications• Autoimmune molecular mimicry (if caused by pathogens) • Diarrhea • Digestion • Foodborne illness • Gastritis • Gastroenteritis (if it has viral causes) • Gut dysbiosis • Immunity • Inflammation • Suspected bacterial, parasitic or viral pathogenesis (incl. detection of antibiotic resistant bacteria)